Engflag

Cidegol C

Quick links to important sections

Cidegol C

Cidegol C_EN

Method of action: Antiseptics And Disinfectants, Disinfectant, Stomatological Preparations, Throat Preparations

Treatment option: Gingivitis, Infection, Candidiasis,Oral, Infant Thrush, Infection Prophylaxis, AIDS / HIV, Stomatitis, Dental, Tuberculosis, Surgery

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cidegol C

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate
Form Aqueous Solution (e.g., oral rinse, topical)
Pharmacological Class Antiseptic and Disinfectant
General Purpose Controlling microorganism growth
Origin Synthetic Compound (Biguanide derivative)

What is Cidegol C and Its Pharmacological Class?

Cidegol C is a medicinal preparation whose primary active component is the powerful broad-spectrum antimicrobial agent, Chlorhexidine Gluconate. It is fundamentally classified as an antiseptic and disinfectant, placing it within the pharmacological group of topical germicides used to control the presence of microorganisms.

This drug is recognized as an essential antiseptic agent, reflecting its established role in public health. This classification reflects the clinically recognized efficacy of the solution as a standard antimicrobial. The drug is used to combat a wide array of pathogens, serving as an effective means of chemical antisepsis with persistent germ-killing action.

Composition, Form, and Origin

Cidegol C is most commonly presented as an aqueous solution, meaning the active substance, Chlorhexidine Gluconate, is dissolved in a water-based vehicle. This core substance is a synthetic compound (a biguanide derivative), developed in a laboratory.

The preparation is formulated as a liquid solution, such as an oral rinse or a topical solution, confirming its designated topical route of administration. Chlorhexidine Gluconate is a cationic biguanide used for its persistent antibacterial properties. This solution is distinctive in its formulation as a single-ingredient product, often targeted for use in scenarios that demand high levels of surface sanitation.

What Is the General Purpose of This Solution?

The general purpose of Cidegol C is to provide prolonged control over the presence of microorganisms, ensuring a sanitary environment on the intended surface. This persistent effect is due to a unique characteristic called substantivity, where the active ingredient chemically binds to the application area, such as the oral mucosa or skin. This sustained binding ensures the germ-killing effect is active over an extended period after the initial application. The fundamental benefit is consistently supporting overall hygiene and cleanliness by maintaining a substantial and prolonged reduction in the microbial load.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Chlorhexidine on WHO EML

What side effects are possible with Cidegol C?

Possible Side Effects and Safety Information

The safety profile of Cidegol C, which contains Chlorhexidine Gluconate, primarily addresses local effects at the site of application and the risk of hypersensitivity reactions, according to official regulatory documentation. The product's side effects are generally classified based on frequency and the body system affected.

Adverse Reaction Classifications

Classification System-Organ Class Examples of Documented Effects
Common Gastrointestinal Discolouration of the teeth and tongue; transient taste disturbances; burning sensation of the tongue (oral rinse).
Very Rare / Frequency Not Known Immune System Disorders Hypersensitivity reactions, including anaphylactic shock; severe rash; urticaria.
Uncommon Skin/Subcutaneous Tissue Irritative skin reactions, pruritus, erythema, and eczema (topical solutions).

Serious Adverse Reactions and Restrictions

The most serious adverse event category documented is anaphylactic shock, a rare but severe systemic allergic reaction reported in official safety summaries. Fatal cases of anaphylaxis have been noted in post-marketing surveillance.

Safety constraints mandate that Cidegol C is contraindicated in individuals with a known history of hypersensitivity to chlorhexidine. For topical formulations, regulatory documents note the risk of chemical burns when used on infants and neonates, leading to specific age restrictions in official labeling. Additionally, discolouration of the teeth and tongue is classified as reversible upon discontinuation of the product. The solution must be kept out of the eyes and ears due to potential injury.

Overdose and Emergency Response

The official regulatory profile for an overdose of Cidegol C (Chlorhexidine Gluconate) is structured around the route of exposure and the potential for severe hypersensitivity. Immediate medical attention must be sought if any signs of a serious allergic reaction occur, such as wheezing, difficulty breathing, widespread severe rash, or swelling of the face. Regulators document the potential for life-threatening outcomes in these cases, including shock, circulatory collapse, and fatal anaphylaxis, requiring immediate emergency care.

Accidental swallowing of the solution is associated with gastrointestinal symptoms, including gastric distress, nausea, and stomach pain. If an ethanol-containing oral rinse is ingested, documented effects can include signs of alcohol intoxication, such as slurred speech or staggering. In cases of ingestion, official guidance mandates contacting a Poison Control Center right away.

Exposure to sensitive areas also carries specific risks. If the solution enters the eye, it can cause serious and permanent eye injury, including corneal epithelial damage. Furthermore, the use of the product in neonates and infants has been associated with the development of chemical burns. Management is strictly symptomatic and supportive treatment, as regulatory documents state that no specific antidote is known for Chlorhexidine Gluconate overdose.

Therapeutic Uses of Cidegol C

What Cidegol C Treats: Main Uses and Benefits

The primary purpose of Cidegol C is to provide supportive assistance in the domain of managing microbial growth and addressing conditions involving localized skin or mucosal irritation. This solution is commonly used for managing topical conditions where antiseptic action is required to maintain hygiene and support the healing environment.

Cidegol C is applied in addressing a range of localized needs and is relevant when surface sanitation is required. It may also assist with reducing the presence of pathogens in specific areas, which supports the management of symptoms related to localized imbalance or minor surface irritations.

This supportive action contributes to improved hygiene during periods of symptoms associated with episodic or fluctuating manifestations of skin or mucosal irritation.

By managing the microbial load, Cidegol C supports the maintenance of a sanitary environment and assists with maintaining functional stability of the treated area during use. It is used when supportive antiseptic relief is needed for conditions presenting with localized discomfort.

Quick Fact: Relevant for maintaining hygiene in affected areas

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

This information is based on the regulatory profile for Cidegol C, which contains Chlorhexidine digluconate.

Contraindicated Populations

Official regulatory documents state that Cidegol C must not be used by individuals with a known hypersensitivity or allergy to Chlorhexidine digluconate or any other ingredient listed in the medicine.

Age-Related Eligibility

  • Infants and Children: Use is not recommended for children under 12 years of age due to insufficient data establishing safety and efficacy.
  • Adults: The medicine is generally intended for use in the adult population.

Special Population Restrictions

Condition/Status Eligibility Classification Restriction Basis
Pregnancy Contraindicated Use is not allowed due to potential risk or lack of established safety data.
Lactation Not Recommended Use should be avoided as the substance may be excreted into human milk.
Wound Depth Conditional Use Avoid applying to wounds that involve more than the superficial skin layers.

Eligibility is strictly limited by official regulatory classifications, which prohibit use in cases of known allergy or restrict use in vulnerable groups like pregnant or breastfeeding individuals.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Cidegol C (Chlorhexidine Gluconate) is uniquely defined by its local action and minimal systemic absorption, as documented in official regulatory sources.

Absence of Systemic Drug Interactions Official documentation confirms that Cidegol C has no known systemic drug-drug interactions with other medicines. This is because, following oral rinse or topical application, the active component is poorly absorbed, resulting in negligible to undetectable levels in the bloodstream. Consequently, there are no documented pharmacokinetic (CYP enzyme or transporter) or pharmacodynamic interactions with systemically administered therapeutic agents.

Local Chemical Incompatibilities The primary interaction pattern involves chemical incompatibility at the application site. Cidegol C, a cationic agent, is antagonized by soaps and other anionic agents. This includes anionic surfactants commonly found in dentifrice (toothpaste). This antagonism can reduce the product's intended antimicrobial effect.

Administration Timing Constraints To preserve the product’s local activity, specific timing rules are imposed by regulatory labels:

  • Dentifrice Separation: Administration of the oral rinse must be separated by at least 30 minutes after using an anionic-containing dentifrice to minimize chemical antagonism.
  • Food and Beverages: The label restricts the immediate consumption of food, beverages, or water following use to maintain the prolonged local binding of the active ingredient. The co-use of other mouthwashes immediately following Cidegol C is also restricted.

Mechanism of Action

Cidegol C (Chlorhexidine Gluconate) functions as a membrane-active agent, employing a non-specific, physicochemical mechanism by engaging its mechanistic cascade, rather than engaging complex human physiological or biochemical signaling pathways. The core action is the rapid, high-affinity electrostatic binding of the drug's positively charged molecule to the negatively charged components of the microbial cell wall and membrane. This binding immediately compromises the structural integrity of the cell, resulting in significant alteration of osmotic control and the leakage of vital intracellular contents. At higher concentrations, the drug penetrates the cell and causes the coagulation of essential enzymes and nucleic acids, directly inhibiting metabolism and replication, which ultimately results in cellular lysis and cessation of microbial viability.

The mechanism also includes substantivity, where the molecule chemically binds to anionic sites on the application surface. This creates a reservoir that slowly desorbs over an extended period. The retention and slow release results in a prolonged, residual surface activity, during which microbial colonization is inhibited. The drug's mechanism is structurally constrained, resulting in limited penetration or inaccessibility to targets against organisms protected by dense, impervious barriers, such as bacterial spores and non-enveloped viruses.

Dosage and Administration Information

Instruction Map: How to use Cidegol C — Administration Guidelines

The administration of Cidegol C is governed by its designation as an antiseptic, with usage patterns varying by dosage form and application site.

Administration Scope

Category Instruction
Route of administration Oromucosal (for oral rinse) and Topical (for skin applications, such as scrubs or cleansers).
Dosing schedule Oral Rinse: 15 mL of undiluted 0.12% solution per application. Topical Scrub: 5 mL applied per segment of the required scrub procedure.
Timing in relation to meals Use after meals. Avoid eating or drinking for approximately 30 minutes following use.
Preparation requirements The oral rinse is used full strength and must not be diluted.
Age-group administration rules The use and dose for children up to 18 years must be determined by a healthcare professional.
Missed-dose rules An occasional missed dose may be ignored if the patient generally adheres to the recommended regimen.
Special procedural conditions The oral solution must be held for 30 seconds and then expectorated (spit out); it must not be swallowed. The mouth should be rinsed with water prior to use if toothpaste was used.

Instruction Classifications (High-Level)

Classification Standard Usage Principle
Administration method type Oromucosal; Topical.
Frequency pattern Twice daily (oral rinse, typically morning and evening).
Basis of use Established clinical protocols and product standards.
Use-context constraints The product is confined to the oral cavity or skin; it must not be mixed with incompatible agents (anionic compounds).

Resulting Procedural Structure

Step sequence:

  • Measure the specific volume of the undiluted solution as instructed.
  • Administer the product only to the approved site (oral cavity or skin) for the specified duration.
  • The oral solution must be expectorated (spit out); topical applications require thorough rinsing and drying.

Connection to the overall use protocol These instructions structure the product's use by clearly defining the topical or oromucosal routes and the precise, concentration-dependent dosing volumes. The administration is further defined by specific time constraints, such as the twice-daily frequency and the non-ingestion rule, ensuring the solution is applied correctly at the intended site.

Recent Clinical Evidence

℮ Research Evidence / Overview of Studies for Cidegol C

Research Exploring Cidegol C's Association with Infection Risk in Healthcare Settings

Research involves Randomized Controlled Trials (RCTs) and Systematic Reviews monitoring adult populations in clinical settings. Studies examined whether topical application of the solution was associated with differences in the risk of conditions such as catheter-related bloodstream infections. Findings describe patterns observed in the studies, though results apply only to the populations studied. Research consistency is lower when examining deeper infections.

Research Exploring Cidegol C's Association with Inflammatory Processes in the Oral Cavity

This evidence, evaluated via numerous RCTs and Meta-analyses, explored whether the solution's use as a rinse was associated with changes in gum inflammation markers (like bleeding) in adult populations. Studies report how symptoms evolved over observation periods extending up to nine months. Observations of long-term outcomes beyond these study periods are not fully established, and follow-up durations were limited in some trials.

Studies Exploring Cidegol C's Association with Outcomes in Critical Care

Research explored the solution's application in the Intensive Care Unit (ICU) setting for patients on mechanical ventilation. These studies monitored whether using the oral rinse was associated with differences in the rates of specific respiratory tract infections. While some studies report how symptoms evolved in specific subgroups, the reported results varied across different cohorts. The research available does not determine a consistent influence on broad outcomes like survival rates.

Long-Term Studies and Follow-up Duration

The evidence base focuses predominantly on short-term or intermediate outcomes. For acute contexts, the follow-up durations were limited to the immediate clinical period. There is limited information for long-term outcomes that persist over many years.

What Is Still Uncertain About Cidegol C

The research identifies several areas where certainty remains low. The evidence quality varies across studies when examining high-risk subgroups. Additionally, research has not consistently evaluated the solution's association with broad, long-term outcomes, such as overall survival.

Key Studies & References WHO Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Cidegol C (FAQ)

Q: Does Cidegol C have a bad taste?

According to official product information, some patients may experience an alteration in how things taste while using Cidegol C oral rinse. The rinse itself has been reported to have a bitter taste by some individuals. These taste changes can potentially affect your perception of the flavors of food and beverages.

Q: Is it safe to use this product if I have dentures or dental fillings?

Regulatory information indicates that Cidegol C can cause staining of oral surfaces, including natural tooth surfaces, dental restorations, and dentures. Staining of certain front-tooth restorations has been reported to be difficult or impossible to remove. Staining on dentures is generally removable with a conventional dental cleaner.

Q: Can I drink alcohol while I am using Cidegol C?

The official product information generally restricts the immediate consumption of any food or beverage, which would include alcohol, following use. This is done to maintain the product’s prolonged local activity. Additionally, product information notes that some formulations of the oral rinse contain alcohol (ethanol) as an ingredient.

Q: Does Cidegol C oral rinse contain any alcohol?

Yes, many brands or formulations of the Cidegol C oral rinse contain alcohol (ethanol) as an inactive ingredient, or excipient. This detail is listed in the Composition section of the regulatory product label. However, some brands are specifically formulated to be alcohol-free.

How should Cidegol C be stored and disposed of?

The official regulatory guidelines for storing and disposing of Cidegol C (Chlorhexidine Gluconate) solution must be strictly followed to ensure product stability and safety.

Storage Requirements

The solution must be stored at controlled room temperature, typically 20 C to 25 C. It is mandatory to protect the product from light and do not freeze the solution. The container must be kept tightly closed and stored in its original packaging to prevent contamination and degradation.

Disposal Instructions

Unused or expired solution must be discarded according to local/national regulations. The preferred disposal method is through an official drug take-back program. Solutions must not be poured down the drain or toilet (into wastewater systems). Finally, all medication must be stored out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagGermany

Equivalent of Cidegol C found in:

A-Z Index: